# Clovis Oncology, Inc.

Clovis Oncology, Inc. is a company headquartered in Boulder, CO, United States.

## Company overview

- **Legal name:** Clovis Oncology, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Boulder, CO, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001466301

## About

Clovis Oncology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001466301, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-02-24, it reported annual revenue of USD 148,757,000; net income of USD -264,524,000; total assets of USD 472,833,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $148.8M (USD 148,757,000)
- **Net income:** -$264.5M (USD -264,524,000)
- **Total assets:** $472.8M (USD 472,833,000)
- **Cash and equivalents:** $143.4M (USD 143,428,000)
- **Operating cash flow:** -$196.1M (USD -196,057,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $164.5M (USD 164,522,000)
- **Net income:** -$369.2M (USD -369,212,000)
- **Total assets:** $605.6M (USD 605,554,000)
- **Cash and equivalents:** $240.2M (USD 240,229,000)
- **Operating cash flow:** -$252.7M (USD -252,728,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $143.0M (USD 143,006,000)
- **Net income:** -$400.4M (USD -400,424,000)
- **Total assets:** $669.6M (USD 669,604,000)
- **Cash and equivalents:** $161.8M (USD 161,833,000)
- **Operating cash flow:** -$323.6M (USD -323,615,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $95.4M (USD 95,388,000)
- **Net income:** -$368.0M (USD -368,009,000)
- **Total assets:** $863.6M (USD 863,560,000)
- **Cash and equivalents:** $221.9M (USD 221,876,000)
- **Operating cash flow:** -$366.0M (USD -365,997,000)

## Recent SEC filings

- Form 8-K — filed 2023-07-11 — period 2023-07-10 — 8-K
- Form 8-K — filed 2023-06-30 — period 2023-06-30 — 8-K
- Form 8-K — filed 2023-06-02 — period 2023-05-26 — 8-K
- Form 8-K — filed 2023-05-03 — period 2023-05-02 — 8-K
- Form 8-K — filed 2023-05-01 — period 2023-05-01 — 8-K
- Form 8-K — filed 2023-04-14 — period 2023-04-14 — 8-K
- Form 8-K — filed 2023-04-06 — period 2023-04-05 — 8-K
- Form 8-K — filed 2023-03-31 — period 2023-03-30 — 8-K
- Form 8-K — filed 2023-03-02 — period 2023-03-01 — 8-K
- Form 8-K — filed 2023-02-16 — period 2023-02-09 — 8-K
- Form 8-K — filed 2023-02-13 — period 2023-02-09 — 8-K
- Form 8-K — filed 2023-01-12 — period 2023-01-06 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/clovis-oncology-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology